Memorial_Sloan_Kettering_Cancer_CenterMemorial_Sloan_Kettering_Cancer_CenterMemorial_Sloan_Kettering_Cancer_Center%D9%85%D8%B1%DA%A9%D8%B2_%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D9%85%D9%85%D9%88%D8%B1%DB%8C%D8%A7%D9%84_%D8%A7%D8%B3%D9%84%D9%88%D9%86%E2%80%93%DA%A9%D8%AA%D8%B1%DB%8C%D9%86%DA%AFMemorial_Sloan-Kettering_Cancer_Center%D7%9E%D7%A8%D7%9B%D7%96_%D7%94%D7%A1%D7%A8%D7%98%D7%9F_%D7%9E%D7%9E%D7%95%D7%A8%D7%99%D7%90%D7%9C_%D7%A1%D7%9C%D7%95%D7%90%D7%9F_%D7%A7%D7%98%D7%A8%D7%99%D7%A0%D7%92Memorial_Sloan-Kettering_Cancer_CenterMemorial_Sloan-Kettering_Cancer_Center%D0%9C%D0%B5%D0%BC%D0%BE%D1%80%D0%B8%D0%B0%D0%BB%D1%8C%D0%BD%D1%8B%D0%B9_%D0%BE%D0%BD%D0%BA%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D1%86%D0%B5%D0%BD%D1%82%D1%80_%D0%B8%D0%BC%D0%B5%D0%BD%D0%B8_%D0%A1%D0%BB%D0%BE%D1%83%D0%BD%D0%B0_%E2%80%94_%D0%9A%D0%B5%D1%82%D1%82%D0%B5%D1%80%D0%B8%D0%BD%D0%B3%D0%B0Q1808012%E7%B4%80%E5%BF%B5%E6%96%AF%E9%9A%86-%E5%87%B1%E7%89%B9%E7%90%B3%E7%99%8C%E7%97%87%E4%B8%AD%E5%BF%83
about
Cornelius P. RhoadsMurray BrennanMathilde KrimAndrew VickersLorenz StuderBobby ZachariaeHediye Erdjument-BromagePaul TempstNikola PavletichDavid W. KissaneKathryn V. AndersonHarold E. VarmusIñigo LandaScott KeeneyMonica Di GiacomoBenedikt WestermannGiovanni CirielloPeter J SchüfflerAndrea VenturaCameron BrennanDebyani ChakravartyFranziska MichorRicardo OtazoKathleen M. FoleyIrene OrlowSarwish RafiqDana HaddadSean CarlinAudrey MauguenIan G. GanleyFabiana PernaOmar Abdel-WahabJoseph M. ScanduraRajmohan MuraliBenjamin DurhamDeborah KukAriela NoyParisa MomtazTroy Z HorvatAndrew J Vickers
P108
P1416
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal CancerImproving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had ChemotherapyA Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerIntrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With MedulloblastomaAnti-LAG-3 or Urelumab Alone and in Combination With Nivolumab in Treating Patients With Recurrent GlioblastomaProstvac in Patients With Biochemically Recurrent Prostate CancerA Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast CancerNivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerNivolumab With or Without Ipilimumab or Relatlimab Before Surgery in Treating Patients With Stage IIIB-IV Melanoma That Can Be Removed by SurgeryPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCombination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairIsatuximab in Treating Patients With High Risk Smoldering Plasma Cell MyelomaVigil + Irinotecan and Temozolomide in Ewing's SarcomaAtezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical CancerVaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal MetastasesA Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot StudyA Safety and Efficacy Study of Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus Subcutaneous Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML)Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical CarcinomaSequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell LymphomaCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaStandard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsPhase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell LymphomaElectronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell CarcinomaThis is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated CancersPhase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaIxazomib Maintenance Study in Patients With AL AmyloidosisTreatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsSitravatinib and Nivolumab in Urothelial Carcinoma StudyEvaluation of Preoperative Functional Magnetic Resonance Imaging (fMRI) in Patients With Brain TumorsA Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi AnemiaChemotherapy and/or Metastasectomy in Treating Participants With Metastatic Colorectal Adenocarcinoma With Lung MetastasesA Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal MalignanciesPU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerSafety, PK, PD, and Antitumor Activity of ARQ 531 in Hematologic MalignanciesPfizer PF-06688992 in Patients With Stage III or Stage IV MelanomaA Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
P6153
Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial LesionsPhase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular SchwannomasExercise in Breast Cancer Survivors (2020-04-30)Clinical Utility of IMPROD bpMRIFatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
P767
Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot StudySingle Agent Pembrolizumab in Subjects With Advanced Adrenocortical CarcinomaSequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell LymphomaConsumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell CarcinomaPhase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaIxazomib Maintenance Study in Patients With AL AmyloidosisTreatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated DonorsDonor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsEvaluation of Preoperative Functional Magnetic Resonance Imaging (fMRI) in Patients With Brain TumorsA Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi AnemiaPU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerPfizer PF-06688992 in Patients With Stage III or Stage IV MelanomaA Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsRetinoblastoma Survivor Study: Assessment of General Health and Quality of LifeTissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled TrialChemotherapy-Induced Changes to Cognition and DNA in Breast Cancer SurvivorsRandomized Controlled Trial of Group Psychotherapy Interventions for Cancer PatientsSunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentIodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory NeuroblastomaMonoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed NeuroblastomaChemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCisplatin and Everolimus in Treating Patients With Advanced Solid TumorsPaclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to CisplatinClofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other DiseaseA Study of RAD001 and Sunitinib in Metastatic Renal Cell CarcinomaA Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsClofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerDoes Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?Randomized Trial Comparing Robotic and Open Radical CystectomyVitamin D Levels in Stage IV Colorectal Cancer PatientsLung Cancer Exercise Training StudyChanges in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance ImagingNeuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer PatientsGeriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian CancerImproving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
P859
description
cancer treatment and research institution in New York City, United States
@en
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
privates Krankenhaus in New York
@de
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in de Verenigde Staten
@nl
בית חולים ומרכז מחקר בארצות הברית
@he
مستشفى
@ar
name
Memorial Sloan Kettering Cancer Center
@en
Memorial Sloan Kettering Cancer Center
@es
Memorial Sloan Kettering Cancer Center
@nl
Memorial Sloan-Kettering Cancer Center
@de
Memorial Sloan-Kettering Cancer Center
@fr
Memorial Sloan-Kettering Cancer Center
@id
Memorial Sloan-Kettering Cancer Center
@it
Sloan-Kettering癌症中心 (MSKCC)
@zh
Мемориальный онкологический центр имени Слоуна — Кеттеринга
@ru
מרכז הסרטן ממוריאל סלואן קטרינג
@he
type
label
Memorial Sloan Kettering Cancer Center
@en
Memorial Sloan Kettering Cancer Center
@es
Memorial Sloan Kettering Cancer Center
@nl
Memorial Sloan-Kettering Cancer Center
@de
Memorial Sloan-Kettering Cancer Center
@fr
Memorial Sloan-Kettering Cancer Center
@id
Memorial Sloan-Kettering Cancer Center
@it
Sloan-Kettering癌症中心 (MSKCC)
@zh
Мемориальный онкологический центр имени Слоуна — Кеттеринга
@ru
מרכז הסרטן ממוריאל סלואן קטרינג
@he
altLabel
MSKCC
@de
MSKCC
@en
MSKCC
@fr
Memorial Sloan Kettering Cancer Center
@fr
Memorial Sloan Kettering Hospital
@en
Memorial Sloan–Kettering Cancer Center
@it
New York Cancer Hospital
@en
Sloan Kettering Hospital
@en
Sloan Kettering
@en
مرکز سرطان مموریال اسلون کترینگ
@fa
prefLabel
Memorial Sloan Kettering Cancer Center
@en
Memorial Sloan Kettering Cancer Center
@es
Memorial Sloan Kettering Cancer Center
@nl
Memorial Sloan-Kettering Cancer Center
@de
Memorial Sloan-Kettering Cancer Center
@fr
Memorial Sloan-Kettering Cancer Center
@id
Memorial Sloan-Kettering Cancer Center
@it
Sloan-Kettering癌症中心 (MSKCC)
@zh
Мемориальный онкологический центр имени Слоуна — Кеттеринга
@ru
מרכז הסרטן ממוריאל סלואן קטרינג
@he